Skip to content

De-implementing PreOp Urine Testing

De-implementation of Unnecessary Pre-Operative Urine Testing

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07411209
Enrollment
6
Registered
2026-02-13
Start date
2026-12-31
Completion date
2030-12-31
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asymptomatic Bacteriuria, Urinary Tract Infection

Keywords

antibiotic stewardship, kicking cauti

Brief summary

This is a randomized study to evaluate the effectiveness and implementation of an intervention to decrease unnecessary urine testing for surgical patients (Less is More for Surgical Urine Testing) across six geographically diverse Veterans Affairs Medical Centers. The intervention will unfold over two years, in three phases: control, intervention, and sustainability.

Detailed description

The purpose of this study is to implement our surgery-tailored evidence based 'Kicking CAUTI' intervention package in diverse surgical settings across the Veterans Affairs Medical Centers (VAMCs), and assess its effectiveness at de-implementing low-value perioperative urine testing and related inappropriate antibiotic prescribing. In this hybrid type 2 effectiveness-implementation study, the investigators will conduct a stepped wedge cluster randomized trial to evaluate the effectiveness, implementation, and cost of the tailored intervention at up to six VAMCs.

Interventions

BEHAVIORALInterventional Project Site Visit

Activities occurring during the 12-month intervention phase * 1:1 meetings introducing the project * Site Visit (once during intervention period) * Interactive teaching cases and didactic sessions * Distribution of algorithm as pocket cards * Access to project materials on SharePoint * Feedback reports on clinical outcomes * Evidence-based order set templates * Learning collaborative webinars * Individualized coaching

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Masking description

This study is a hybrid type 2 effectiveness/implementation study with a dual focus on clinical effectiveness and implementation outcomes using a stepped wedge cluster randomized trial among six recruited VAMCs.

Intervention model description

Stepped Wedge Cluster Randomized Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Medical Centers part of the Veterans Affairs Health Administration (VAMCs) * VAMCs that perform standard, intermediate, or advanced surgical procedures * VAMCs in which perioperative urine testing is performed among greater than 10% of their non-urologic, non-transplant surgery procedures

Exclusion criteria

* VAMCs that only perform ambulatory surgery (outpatient/day surgery only) * VAMCs that do not perform urine testing among at least 10% of their non-urologic, non-transplant surgery procedures * VAMCs that already have implemented interventions to reduce perioperative urine testing * VAMCs' units performing genitourinary or transplant surgeries * Database of patients with a diagnosis of urinary tract infection within 30 days before surgery

Design outcomes

Primary

MeasureTime frameDescription
Number of Urine Testing Performedup to 48 monthsThroughout the study period, the research team will generate monthly lists of all urinalyses and urine cultures performed within 30 days before and 30 days after included procedures. The study team will chart review theses cases and determine whether the urine test was done on an asymptomatic patient or whether the test was justified based on UTI symptoms.

Secondary

MeasureTime frameDescription
Number of Days of Therapyup to 48 monthsDays of therapy is an aggregate sum of days on which an antimicrobial agent was administered to an individual patient. The investigators will include systemic antibacterial agents administered within 30 days before and 30 days after surgery. The investigators will exclude doses given as standard preoperative prophylaxis and antimicrobial agents that are not used for urinary tract infections.
Budget Impact Analysisup to 48 monthsTime spent by sites will be converted into cost by multiplying the hourly wage rate plus benefits for each type of healthcare professional involved in the intervention

Countries

United States

Contacts

CONTACTMarin L Schweizer-Looby, PhD BS
Marin.Schweizer-Looby@va.gov(608) 256-1901
PRINCIPAL_INVESTIGATORMarin L. Schweizer-Looby, PhD BS

William S. Middleton Memorial Veterans Hospital, Madison, WI

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026